Am J Physiol Endocrinol Metab (2007) 293(6):E174655
Starting Dose 0.3 mg In the phase 2 weight study, dosing started low at 0.3 mg weekly and was raised every 2 weeks to reduce nausea [1]
KLOW best for: reactive or redness-prone skin, active rosacea or inflammatory acne, post-procedure recovery (laser, microneedling), chronic low-grade facial inflammation
Specific Improvements: It balances appetite through central regulation, preventing overeating due to excessive appetite while addressing the common issue of reduced appetite in myocardial infarction patients
Even without treatment, it typically resolves on its own during adulthood
This study was approved by the Institutional Committee of Ethics in Research involving human beings from the health sciences sector of UFPA (CEP-ICS/UFPA), under n 3544380 and CAAE 12776619.0.0000.0018